SMP-3124LP

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SMP-3124LP, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: SMP-3124LP in Adults With Advanced Solid Tumors [Phase 1, Phase 2]